Albumin-Fused Antibodies May Reduce Fetal Exposure to Therapeutics

Summary

Preclinical research demonstrates that fusing IgG antibodies to albumin reduces placental transport and fetal exposure in mice models, suggesting albumin as a viable fusion partner for therapeutic antibodies.